Join Finnegan attorneys Justin Hasford, Matthew Hlinka, and Priya Dalal as they explore recent developments in patent case law with a focus on the pharmaceutical, chemical, and biotech fields. During this free interactive webinar, you will be apprised of these developments, which can substantially impact patent protection of innovations in these areas.

Topics to be discussed include:

• Chemical and pharmaceutical development is highly complex and unpredictable, and various approaches are not “obvious to try,” especially in the absence of guiding data or information in the prior art

• Generic pharmaceutical companies can be found liable for induced infringement even when utilizing “skinny labels."

• Patent claims with broad functional language can impose a high burden for fulfilling the enablement requirement.